Enzyre: Funding, Investors & Team (Sep 2026)
Enzyre, a UMC St. Radboud spinoff business, began operations in March 2017. It was established with the goal of creating novel diagnostic techniques to enable individualized medicine. The business has the ambition to develop a point of care (POC) diagnostic platform that will use chemiluminescence to measure a wide range of enzyme processes.
Enzyre has raised $11.8M across 1 funding round on record, the most recent a Series A of $11.8M announced in Nov 2022.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Enzyre Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Enzyre Funding Rounds
Enzyre Founders and Leadership Team
No contact details are on record for this team yet.
Enzyre Funding Compared to Other Health Care Startups
Enzyre's latest round of $11.8M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enzyre in Health Care and Nijmegen
Companies Similar to Enzyre
The most cutting-edge polymer-based platform of restorative cardiovascular devices was created by Xeltis.…
Vitestro revolutionizes the way patients are cared for by introducing independent blood-drawing technology.
ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and…
Speaklee is a company that utilizes AI technology to create a speech assistant tool for children who have…
CardiacBooster is a company in the medical field that creates percutaneous devices to assist the left…
Plasmacure offers a patented cold plasma solution designed to heal chronic wounds. They provide services in…
Hy2Care® is a company that originated from the MIRA Institute at the University Twente in the Netherlands, a…
Platos Health is a technology startup dedicated to increasing access to preventive healthcare. Our current…
AVIGI Therapeutics is leading the way in creating new drugs through a rational approach that combines…
Sirius medical helps in improving healthcare for cancer patients by developing medical devices that helps in…
PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health…
Enzyre Funding FAQs
What does Enzyre do?
Enzyre, a UMC St. Radboud spinoff business, began operations in March 2017. It was established with the goal of creating novel diagnostic techniques to enable individualized medicine. The business has the ambition to develop a point of care (POC) diagnostic platform that will use chemiluminescence to measure a wide range of enzyme processes.
How much funding has Enzyre raised?
Enzyre has raised $11.8M across 1 round on record. The most recent is a Series A of $11.8M announced in Nov 2022.
When did Enzyre last raise funding?
Enzyre's most recent funding round on record is a Series A of $11.8M, announced in Nov 2022.
Who is the CEO of Enzyre?
Guido Maertens is listed as CEO at Enzyre.
Where is Enzyre headquartered?
Enzyre is based in Nijmegen, Gelderland, Netherlands.
How many employees does Enzyre have?
Enzyre is in the 11-50 employee band.
How does Enzyre's funding compare to other Health Care startups?
Enzyre's latest round of $11.8M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Enzyre Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enzyre is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.